HK1206995A1 - Methods for increasing cftr activity cftr - Google Patents
Methods for increasing cftr activity cftrInfo
- Publication number
- HK1206995A1 HK1206995A1 HK15107706.3A HK15107706A HK1206995A1 HK 1206995 A1 HK1206995 A1 HK 1206995A1 HK 15107706 A HK15107706 A HK 15107706A HK 1206995 A1 HK1206995 A1 HK 1206995A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- cftr
- methods
- increasing
- activity
- cftr activity
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261621043P | 2012-04-06 | 2012-04-06 | |
PCT/US2013/032268 WO2013151758A2 (en) | 2012-04-06 | 2013-03-15 | Methods for increasing cftr activity |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1206995A1 true HK1206995A1 (en) | 2016-01-22 |
Family
ID=49301152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15107706.3A HK1206995A1 (en) | 2012-04-06 | 2015-08-10 | Methods for increasing cftr activity cftr |
Country Status (8)
Country | Link |
---|---|
US (2) | US20150065539A1 (xx) |
EP (1) | EP2833885A4 (xx) |
JP (1) | JP6525203B2 (xx) |
CN (1) | CN104619321A (xx) |
AU (2) | AU2013243857A1 (xx) |
CA (1) | CA2869257A1 (xx) |
HK (1) | HK1206995A1 (xx) |
WO (1) | WO2013151758A2 (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5409010B2 (ja) | 2005-12-28 | 2014-02-05 | バーテックス ファーマシューティカルズ インコーポレイテッド | N−[2,4−ビス(1,1−ジメチルエチル)−5−ヒドロキシフェニル]−1,4−ジヒドロ−4−オキソキノリン−3−カルボキサミドの固体形態 |
CA2963945C (en) | 2014-10-07 | 2023-01-10 | Vertex Pharmaceuticals Incorporated | Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH690023A5 (de) * | 1996-02-02 | 2000-03-31 | Medichemie Ag | Mittel zur Behandlung krankhafter Zellveränderungen der Nasenschleimhaut. |
US20040266883A1 (en) * | 1999-10-27 | 2004-12-30 | Yale University | Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
US7541466B2 (en) * | 2003-12-23 | 2009-06-02 | Genzyme Corporation | Tetrahydroisoquinoline derivatives for treating protein trafficking diseases |
CN102231990B (zh) | 2008-08-13 | 2013-09-25 | 沃泰克斯药物股份有限公司 | N-[2,4-双(1,1-二甲基乙基)-5-羟基苯基]-1,4-二氢-4-氧代喹啉-3-甲酰胺的药物组合物和其给药 |
US20100256184A1 (en) * | 2008-08-13 | 2010-10-07 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
EP2475360A1 (en) * | 2009-09-12 | 2012-07-18 | Reckitt Benckiser LLC | Use of guaifenesin for inhibiting mucin secretion |
EP2547335A4 (en) * | 2010-03-15 | 2014-04-16 | Univ Virginia Commonwealth | AEROSOLIC DAPSONE AS THERAPY AGAINST INFLAMMATION OF THE RESPIRATORY SYSTEM AND ANOMALY OF MUCOCILIARY TRANSPORT |
EP3037415A1 (en) * | 2010-03-19 | 2016-06-29 | Vertex Pharmaceuticals Inc. | Solid form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
WO2012158885A1 (en) * | 2011-05-18 | 2012-11-22 | Concert Pharmaceuticals Inc. | Deuterated derivatives of ivacaftor |
-
2013
- 2013-03-15 EP EP13772725.1A patent/EP2833885A4/en not_active Withdrawn
- 2013-03-15 JP JP2015504599A patent/JP6525203B2/ja not_active Expired - Fee Related
- 2013-03-15 WO PCT/US2013/032268 patent/WO2013151758A2/en active Application Filing
- 2013-03-15 AU AU2013243857A patent/AU2013243857A1/en not_active Abandoned
- 2013-03-15 US US14/387,818 patent/US20150065539A1/en not_active Abandoned
- 2013-03-15 CA CA2869257A patent/CA2869257A1/en not_active Abandoned
- 2013-03-15 CN CN201380023856.4A patent/CN104619321A/zh active Pending
-
2015
- 2015-08-10 HK HK15107706.3A patent/HK1206995A1/xx unknown
-
2017
- 2017-04-28 US US15/582,260 patent/US10300052B2/en not_active Expired - Fee Related
-
2018
- 2018-01-10 AU AU2018200192A patent/AU2018200192B9/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
US20150065539A1 (en) | 2015-03-05 |
AU2018200192B9 (en) | 2019-07-25 |
AU2018200192B2 (en) | 2019-06-06 |
CN104619321A (zh) | 2015-05-13 |
JP2015521157A (ja) | 2015-07-27 |
EP2833885A2 (en) | 2015-02-11 |
US10300052B2 (en) | 2019-05-28 |
CA2869257A1 (en) | 2013-10-10 |
WO2013151758A2 (en) | 2013-10-10 |
EP2833885A4 (en) | 2015-12-16 |
AU2018200192A1 (en) | 2018-02-01 |
JP6525203B2 (ja) | 2019-06-05 |
US20170266177A1 (en) | 2017-09-21 |
AU2013243857A1 (en) | 2014-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1250690A1 (zh) | 方法 | |
HK1208363A1 (en) | New methods | |
GB201411223D0 (en) | None | |
GB201211077D0 (en) | Two-piece can | |
EP2833358A4 (en) | DISK | |
GB2507760B (en) | Methods | |
PL2838352T3 (pl) | Wóz paszowy | |
EP2834351A4 (en) | ACTIVITY OF METABOLITE MODIFIED BY AN ENZYME | |
GB2502122B (en) | Amplifier | |
GB201208874D0 (en) | Methods | |
ZA201409022B (en) | 3-o-heteroaryl-ingenol | |
HU4381U (en) | Arrangement for divided enery-production | |
GB201218867D0 (en) | Acoustic pick-up assemblies | |
GB2500883B (en) | Improved saw-horse | |
HK1206995A1 (en) | Methods for increasing cftr activity cftr | |
GB201204280D0 (en) | Methods | |
HK1212895A1 (zh) | 用於免疫調節的沙奎那韋- | |
GB201208756D0 (en) | Methods | |
GB201215582D0 (en) | Biohaven | |
GB201213825D0 (en) | Damper-device for bouncing-device | |
TWM433497U (en) | Structure for jacklight | |
GB201220686D0 (en) | Methods | |
AP2012000550S (en) | E-horn methods | |
GB201216074D0 (en) | Methods | |
GB201410091D0 (en) | None |